Synthetic Cranioplasty PEEK Versus UHMWP
Cranioplasty Using Patient Specific Implants Polyether Ether Ketone Versus Ultra-High Molecular Weight Polyethylene: A Randomized Controlled Trial
1 other identifier
interventional
22
1 country
1
Brief Summary
The purpose of this study is to report the investigators experience with synthetic reconstruction of cranial defects using computer guided milled UHMWP, in terms of benefits and limitations both clinically and radiographically in comparison to PEEK implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2021
CompletedFirst Submitted
Initial submission to the registry
January 31, 2022
CompletedFirst Posted
Study publicly available on registry
February 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2023
CompletedSeptember 5, 2023
August 1, 2023
1.6 years
January 31, 2022
August 31, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Cosmetic patient satisfaction
Method: Questionnaire, Satisfaction Scale \[ 1 Dissatisfied - 5 Highly satisfied \]
6 months
Secondary Outcomes (2)
Overall complications
6 months
implant failure
6 months
Study Arms (2)
UHMWP Cranioplasty
EXPERIMENTALsynthetic reconstruction of cranial defects using computer guided milled UHMWP implants
PEEK Cranioplasty
ACTIVE COMPARATORsynthetic reconstruction of cranial defects using computer guided milled PEEK
Interventions
Eligibility Criteria
You may qualify if:
- Cranial defect patients
- Patients eligible for simultaneous craniectomy and cranioplasty.
- ASA I \& II
You may not qualify if:
- Active infection.
- Medically compromised patients (ASA ≥3).
- Hydrocephalus/Brain Swelling
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Nasser Institute Hospital
Cairo, Shubra, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mamdouh A Sayed, Professor
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
January 31, 2022
First Posted
February 22, 2022
Study Start
November 30, 2021
Primary Completion
July 21, 2023
Study Completion
July 21, 2023
Last Updated
September 5, 2023
Record last verified: 2023-08